Research Article
Low Total Testosterone Levels in Men with Newly Diagnosed Early-Onset Type 2 Diabetes: A Cross-Sectional Study in China
Table 1
General characteristics between two groups.
| | Early-onset T2DM | Late-onset T2DM | |
| | Number | 63 | 90 | — | | Age (year) | | | <0.001 | | BMI (kg/m2) | | | 0.002 | | WC (cm) | | | <0.001 | | HbA1c (%) | | | 0.022 | | TC (mmol/L) | 5.3 (4.54, 6.02) | 5.08 (4.31, 5.77) | 0.116 | | TG (mmol/L) | 2.95 (1.54, 4.25) | 1.81 (1.27, 2.41) | <0.001 | | HDL (mmol/L) | 0.93 (0.83, 1.07) | 1.02 (0.92, 1.15) | 0.009 | | LDL (mmol/L) | 2.91 (2.46, 3.72) | 2.87 (2.58, 3.44) | 0.392 | | ApoA-1 (g/L) | | | 0.119 | | ApoB (g/L) | | | <0.001 | | ApoA-1/ApoB | | | <0.001 | | FBG (mmol/L) | | | 0.055 | | FC-p (ng/mL) | 1.6 (1.06, 2.45) | 1.69 (1.24, 2.1) | 0.792 | | PC-p (ng/mL) | 2.78 (1.81, 5.76) | 4.06 (2.35, 5.33) | 0.101 | | FGLA (pg/mL) | 125.16 (102.14, 151.2) | 125.3 (104.04, 136.86) | 0.605 | | PGLA (pg/mL) | 155.13 (132.28, 181.28) | 142.34 (125.68, 169.41) | 0.285 | | HOMA-IR | 1.82 (1.14, 2.7) | 1.61 (1.23, 2.15) | 0.299 | | GAD-Ab (IU/mL) | 0.76 (0.45, 1.30) | 0.95 (0.43, 1.83) | 0.257 | | ICA-Ab positive (%) | 0 | 0 | — | | Smoking (%) | 34.92 | 42.89 | 0.099 | | Hypertension (%) | 25.40 | 33.33 | 0.371 |
|
|
BMI: body mass index; WC: waist circumference; HbA1c: glycated hemoglobin; TC: total cholesterol; TG: triglyceride; LDL: low-density lipoprotein; HDL: high-density lipoprotein; ApoA-1: apolipoprotein A-1; ApoB: apolipoprotein B; FBG: fasting blood glucose; FC-P: fasting C-peptide; PC-p: postprandial C-peptide; FGLA: fasting glucagon; PGLA: postprandial glucagon; HOMA-IR: homeostatic model assessment of insulin resistance; GAD-Ab: glutamic acid decarboxylase antibody; ICA-Ab: islet cell autoantibodies. Data were presented as or median (interquartile range). |
